GoodRx partners with pharmacy benefits managers (PBMs) who negotiate discounted prescription prices directly with pharmacies.

BofA lowered the firm’s price target on GoodRx (GDRX) to $4.25 from $4.50 and keeps an Underperform rating on the shares after the company ...

The National Community Pharmacists Association has joined a class action lawsuit against GoodRx, as well as CVS Caremark, ...

The average price per insulin unit hit a 10-year low in 2024, largely driven by federal actions and voluntary price cuts from drugmakers, according to a Jan. 15 GoodRx report.

GoodRx (NASDAQ:GDRX) is facing lawsuits from several independent pharmacies who are accusing the company of working with ...